Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | DPP4 | P27487 | 6/20 | 0.68 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.63 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.63 |
| ▸ | DRD1 | P21728 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.56 |
| ▸ | DHFR | P00374 | 1/20 | 0.53 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.52 |
| ▸ | FLT4 | P35916 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
| ▸ | RARB | P10826 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4575476 | 1.00 | KMT2A (0.69) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| SCHEMBL13576371 | 1.00 | KMT2A (0.69) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL10652931 | 0.99 | KMT2A (0.68) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL10824865 | 0.95 | KMT2A (0.66) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| SCHEMBL11022634 | 0.94 | DPP4 (0.68) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL20394712 | 0.93 | DPP4 (0.67) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| SCHEMBL9177508 | 0.89 | DPP4 (0.65) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| SCHEMBL9177523 | 0.89 | DPP4 (0.65) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| SCHEMBL9177514 | 0.89 | DPP4 (0.65) | KMT2ADPP4CHRM2ALDH1A1POLB | |
| SCHEMBL10928412 | 0.89 | DPP4 (0.64) | KMT2ADPP4CHRM2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0394685-A2 | (S)-7-(3-Amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid | WARNER-LAMBERT COMPANY (US) | 1990-10-31 | — | — | EP | claimed |
| US-4916141-A | ANTIBACTERIAL | WARNER-LAMBERT COMPANY (US) | 1990-04-10 | — | — | US | claimed |
| JP-2289568-A | — | — | None | — | — | JP | disclosed |
| US-20250295790-A1 | LECTIN-TARGETING CONJUGATES | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| US-20230285572-A1 | TARGETED DELIVERY OF THERAPEUTIC AGENTS | SEPELO THERAPEUTICS, LLC | 2023-09-14 | — | — | US | disclosed |
| CN-116437961-A | Targeted delivery of therapeutic agents | 赛佩罗疗法有限责任公司 | 2023-07-14 | — | — | CN | disclosed |
| EP-4188433-A2 | TARGETED DELIVERY OF THERAPEUTIC AGENTS | Sepelo Therapeutics, LLC (US) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022031761-A2 | TARGETED DELIVERY OF THERAPEUTIC AGENTS | SEPELO THERAPEUTICS, LLC (US) | 2022-02-10 | — | — | WO | disclosed |
| EP-0394685-A3 | (S)-7-(3-AMINO-1-PYRROLIDINYL)-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID | WARNER-LAMBERT COMPANY (US) | 1991-09-25 | — | — | EP | disclosed |
| EP-0394685-A3 | (S)-7-(3-AMINO-1-PYRROLIDINYL)-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID | WARNER-LAMBERT COMPANY (US) | 1991-09-25 | — | — | EP | disclosed |
| JP-H02289568-A | (S)-7-(3-AMINO-1-PYRROLIDINYL)-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID | WARNER LAMBERT CO | 1990-11-29 | — | — | JP | disclosed |
| EP-0394685-A2 | (S)-7-(3-Amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid | WARNER-LAMBERT COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0394685-A2 | (S)-7-(3-Amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid | WARNER-LAMBERT COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0394685-A2 | (S)-7-(3-Amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid | WARNER-LAMBERT COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| US-4916141-A | ANTIBACTERIAL | WARNER-LAMBERT COMPANY (US) | 1990-04-10 | — | — | US | disclosed |
| US-4916141-A | ANTIBACTERIAL | WARNER-LAMBERT COMPANY (US) | 1990-04-10 | — | — | US | disclosed |
| US-4916141-A | ANTIBACTERIAL | WARNER-LAMBERT COMPANY (US) | 1990-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295790-A1 | LECTIN-TARGETING CONJUGATES | MASP2, LGALS3BP, LGALS1 | KMT2A 4324/4885DPP4 161/4885CHRM2 3211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.